Advisors Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$40.8K Buy
+2,436
New +$40.8K ﹤0.01% 1299
2021
Q1
Sell
-1,281
Closed -$12K 1528
2020
Q4
$12K Sell
1,281
-5,035
-80% -$47.2K ﹤0.01% 1497
2020
Q3
$57K Sell
6,316
-789
-11% -$7.12K ﹤0.01% 1391
2020
Q2
$88K Sell
7,105
-527
-7% -$6.53K ﹤0.01% 1325
2020
Q1
$69K Sell
7,632
-148
-2% -$1.34K ﹤0.01% 1273
2019
Q4
$76K Sell
7,780
-52
-0.7% -$508 ﹤0.01% 1356
2019
Q3
$54K Buy
7,832
+41
+0.5% +$283 ﹤0.01% 1392
2019
Q2
$72K Buy
7,791
+1,496
+24% +$13.8K ﹤0.01% 1358
2019
Q1
$99K Sell
6,295
-3,802
-38% -$59.8K ﹤0.01% 1517
2018
Q4
$156K Sell
10,097
-461
-4% -$7.12K ﹤0.01% 1254
2018
Q3
$227K Sell
10,558
-19,287
-65% -$415K ﹤0.01% 1221
2018
Q2
$726K Sell
29,845
-4,127
-12% -$100K 0.01% 944
2018
Q1
$636K Sell
33,972
-679
-2% -$12.7K 0.01% 1001
2017
Q4
$657K Sell
34,651
-4,249
-11% -$80.6K 0.01% 1002
2017
Q3
$685K Buy
38,900
+5,470
+16% +$96.3K 0.01% 982
2017
Q2
$1.11M Buy
33,430
+9,136
+38% +$304K 0.02% 843
2017
Q1
$780K Buy
24,294
+643
+3% +$20.6K 0.01% 947
2016
Q4
$857K Sell
23,651
-1,520
-6% -$55.1K 0.01% 940
2016
Q3
$1.16M Buy
25,171
+889
+4% +$40.9K 0.02% 810
2016
Q2
$1.22M Sell
24,282
-3,190
-12% -$160K 0.02% 816
2016
Q1
$1.47M Sell
27,472
-1,569
-5% -$84K 0.02% 738
2015
Q4
$1.91M Sell
29,041
-10,148
-26% -$666K 0.03% 673
2015
Q3
$2.21M Sell
39,189
-181
-0.5% -$10.2K 0.04% 593
2015
Q2
$2.33M Sell
39,370
-47,828
-55% -$2.83M 0.03% 617
2015
Q1
$5.43M Sell
87,198
-38,834
-31% -$2.42M 0.07% 347
2014
Q4
$7.25M Sell
126,032
-44,932
-26% -$2.58M 0.1% 264
2014
Q3
$9.19M Sell
170,964
-29,817
-15% -$1.6M 0.13% 211
2014
Q2
$10.5M Buy
200,781
+5,521
+3% +$289K 0.15% 189
2014
Q1
$10.3M Buy
195,260
+41,444
+27% +$2.19M 0.16% 180
2013
Q4
$6.17M Buy
153,816
+43,836
+40% +$1.76M 0.1% 269
2013
Q3
$4.16M Buy
109,980
+44,919
+69% +$1.7M 0.07% 330
2013
Q2
$2.55M Buy
+65,061
New +$2.55M 0.05% 417